InsiderGauge
Checking updates…
Dashboard

Klein Lawrence Ottoinsider trades

In SEC Form 4 filings, Klein Lawrence Otto is listed as Chief Executive Officer of Oruka Therapeutics, Inc. (ORKA). In the last 90 days, Klein Lawrence Otto sold $9.21M of Oruka Therapeutics, Inc. (ORKA) on the open market and bought none. 6 of the 7 sales were reported under a 10b5-1 trading plan.

Companies and roles

CompanyRoleTransactionsLast filed
ORKAOruka Therapeutics, Inc.Chief Executive Officer11Oct 2

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-01

CompanyTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
ORKAOruka Therapeutics, Inc.Oct 1Oct 2M25,000$7.80$195,000948,128YesForm 4
ORKAOruka Therapeutics, Inc.Oct 1Oct 2S16,246$83.40Sale −$1,354,882931,882YesForm 4
ORKAOruka Therapeutics, Inc.Oct 1Oct 2S8,554$84.03Sale −$718,755923,328YesForm 4
ORKAOruka Therapeutics, Inc.Oct 1Oct 2S200$84.78Sale −$16,956923,128YesForm 4
ORKAOruka Therapeutics, Inc.Oct 1Oct 2M · derivative25,000$7.80$195,0001,528,513YesForm 4
ORKAOruka Therapeutics, Inc.Sep 15Sep 15S2,452$95.71Sale −$234,681923,128NoForm 4
ORKAOruka Therapeutics, Inc.Sep 1Sep 1M75,000$7.80$585,0001,000,580YesForm 4
ORKAOruka Therapeutics, Inc.Sep 1Sep 1S6,604$90.79Sale −$599,556993,976YesForm 4
ORKAOruka Therapeutics, Inc.Sep 1Sep 1S63,596$91.90Sale −$5,844,237930,380YesForm 4
ORKAOruka Therapeutics, Inc.Sep 1Sep 1S4,800$92.44Sale −$443,691925,580YesForm 4
ORKAOruka Therapeutics, Inc.Sep 1Sep 1M · derivative75,000$7.80$585,0001,553,513YesForm 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.